Sublingual Placebo
Sublingual Placebo is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Clinical Trials (6)
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6